Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.
about
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein functionTRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart blockStructural organization and Zn2+-dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52Origin and diversification of TRIM ubiquitin ligases.Mass spectrometric and peptide chip characterization of an assembled epitope: analysis of a polyclonal antibody model serum directed against the Sjøgren/systemic lupus erythematosus autoantigen TRIM21.Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of alpha(1D) L-type Ca channel.Role of calcium channels in congenital heart blockImpaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.Congenital heart block maternal sera autoantibodies target an extracellular epitope on the α1G T-type calcium channel in human fetal hearts.Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice.Neonatal Lupus erythematosus Following Rheumatoid Arthritis: Case Report and Literature Review.Lupus and pregnancy: complex yet manageable.Maternal and neonatal outcomes in pregnant women with autoimmune diseases in Pavia, Italy.Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus ErythematosusUmbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.Congenital heart block: evidence for a pathogenic role of maternal autoantibodiesAutoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response.Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophagesMaternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients.The tight junction protein CAR regulates cardiac conduction and cell-cell communication.Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block.Pathogenicity and proteomic signatures of autoantibodies to Ro and La.Management of pregnancy in systemic lupus erythematosus.Cardiac Fibroblast Transcriptome Analyses Support a Role for Interferogenic, Profibrotic and Inflammatory Genes in Anti-SSA/Ro-Associated Congenital Heart Block.Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response.A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias.Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block.Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein.Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics.Autoantibodies in Sjögren's Syndrome.Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
P2860
Q24684586-986168A9-0534-4DCF-8CCC-97E3F1732CDEQ27650357-369C67D3-1EAD-49EA-8DD4-A98C56B51F8AQ28193953-54D88BCD-AFF2-47EA-B2FE-07BA03988D04Q28257418-E04DC39D-F1CB-48B6-BD7A-4DCA322AC06EQ30424095-0D8E759C-F466-43A2-AEF7-C3A84B6D1429Q30431292-C9A30D73-D6F2-452E-A787-85CDCB0075C1Q33653642-5510D271-9E44-4F72-8FA5-CB1EA5B19DEBQ34149267-A4F35E15-BBB7-4120-9D23-762AC21BD8DEQ34945212-856FB9E5-B208-40F2-AABE-0923B19D6D51Q34988528-9E93710C-31EE-48BF-B91E-BF26E5A1523CQ35103440-39A4A260-1ED5-470A-8424-1849BA572EA2Q35118567-7579E0D4-2706-46B2-8BC0-22E45B93BFEEQ35575093-91134E95-18DB-4CC7-A981-2DFCAFA5300FQ35871745-9A38AFB8-8C50-4690-8C68-0DFB6EE3B5F9Q36026299-72876F3B-50C8-4D03-A0EF-B994049B538DQ36146961-79A8D06A-97D7-47EC-AE1D-19BEE456DD69Q36245765-3FCBC25D-938E-4866-AC76-ACCD11779B0AQ36436250-DC047ECB-2CCF-4FFC-970D-81C97275C316Q36570988-313E4A40-942A-4C69-85B9-74C9230DA7CAQ36577483-24EA1C7A-55C7-4B89-9765-6261671AF91AQ36593698-695705EF-AA1F-42FD-BDCB-ECEE83EF9967Q36733075-3329804E-68A8-483F-9908-6FC2D0D2CC5FQ36916388-D8B8516B-0BE8-4324-BE09-B8247A2218D5Q36951063-A2E57CE6-09A5-41CD-AD7F-47F2711A9919Q37077121-E8AD8644-8BE9-4382-AE3B-F80D3C51AF30Q37976260-79FD7632-CB35-434F-8AF2-1EE96C82AF21Q38036105-9386B507-AD19-4B2C-9C95-312CB931DA17Q38720234-A9168D77-E8B9-47B3-BDE4-70603E92D754Q39134569-11ADE49C-0345-4B7A-9A70-3BEF7566D5EEQ39247284-38A54A07-3790-4261-A983-C7B2E6A030D4Q39282353-112187CE-34EB-48FE-8F80-95603132E96DQ43421348-176CB6AF-5EDE-44DD-B4AD-0AD34FE719BBQ44355666-6AD20197-6A7B-403A-89C9-FFD00803042FQ44381933-52ABE7BF-67F1-441B-AB8C-7555B18F665EQ45245825-4E70E290-0630-40CF-B5E7-EF5F791FFD8AQ50632451-D14E7EAC-057F-44CA-9CA2-AC16EB9D9BCBQ50926832-A031AE44-8D95-44C1-A952-9B7E921DD2F6Q51557775-619B1555-648C-4329-AB75-2DCF42A8127CQ51686879-5FC3ED62-077D-43E0-A434-3ED60CE0FDA2Q52597638-E412B820-CEB0-4186-9F01-41E529266B5D
P2860
Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Ro/SSA autoantibodies directly ...... ediate congenital heart block.
@ast
Ro/SSA autoantibodies directly ...... ediate congenital heart block.
@en
type
label
Ro/SSA autoantibodies directly ...... ediate congenital heart block.
@ast
Ro/SSA autoantibodies directly ...... ediate congenital heart block.
@en
prefLabel
Ro/SSA autoantibodies directly ...... ediate congenital heart block.
@ast
Ro/SSA autoantibodies directly ...... ediate congenital heart block.
@en
P2093
P2860
P356
P1476
Ro/SSA autoantibodies directly ...... ediate congenital heart block.
@en
P2093
Lars Ottosson
Maria Sunnerhagen
Peter Thorén
Saad Muhallab
Stina Salomonsson
Sven-Erik Sonesson
Tomas Olsson
Vijay K Kuchroo
P2860
P356
10.1084/JEM.20041859
P407
P577
2005-01-01T00:00:00Z